Rx Propellant to invest $100 mn in new life sciences campus in Hyderabad’s Genome Valley
Hyderabad, Feb 17 (TNT): Rx Propellant on Tuesday announced an investment of $100 million to develop a large-format, integrated life sciences campus in Genome Valley, reinforcing its long-term commitment to India’s research and development ecosystem. The platform, established by Actis and par of General Atlantic, […….]
